Amphetamine is a controlled psychoactive substance subject to international scheduling under the UN Convention on Psychotropic Substances, reflecting its abuse potential, dependence liability, and CNS pharmacological potency. Its mechanism involves modulation of monoaminergic neurotransmission—typically through transporter inhibition or promotion of catecholamine and serotonin release—producing stimulant, entactogenic, or hallucinogenic effects. Despite controlled status, Amphetamine may be a legitimate pharmaceutical manufacturing intermediate or research compound requiring formal PDE and OEL derivation to govern occupational exposures during synthesis and handling.
The OEB assigned to Amphetamine in pharmaceutical manufacturing is determined by structured potency banding based on its pharmacological target, NOAEL from repeat-dose studies, genotoxic classification under ICH M7, and reproductive toxicant status.
